# Myopia Progression and the Effect of 7-Methylxanthine

> **NCT00263471** · PHASE2 · UNKNOWN · sponsor: **Trier Research Laboratories** · enrollment: 90 (—)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** 7-methylxanthine

## Key facts

- **NCT ID:** NCT00263471
- **Lead sponsor:** Trier Research Laboratories
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 90 (—)
- **Last updated:** 2005-12-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263471, "Myopia Progression and the Effect of 7-Methylxanthine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00263471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*